NCT00948402View on ClinicalTrials.gov

PED/PEA-15 Protein, PCOS, Obesity, Insulin Sensitivity Indexes, Metformin, Oral Contraceptives

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

January 31, 2009

Conditions
Polycystic Ovarian SyndromeInsulin Sensitivity
Interventions
DRUG

Metformin

metformin 1250 mg three times daily

DRUG

oral contraceptive

30 µg ethinylestradiol plus 30 mg drospirenone 21 day/month.

All Listed Sponsors
lead

Federico II University

OTHER

NCT00948402 - PED/PEA-15 Protein, PCOS, Obesity, Insulin Sensitivity Indexes, Metformin, Oral Contraceptives | Biotech Hunter | Biotech Hunter